|
1
|
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
|
JAMA
|
2008
|
13.35
|
|
2
|
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
|
Breast Cancer Res
|
2004
|
4.54
|
|
3
|
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
|
J Natl Cancer Inst
|
2005
|
2.99
|
|
4
|
Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
2.83
|
|
5
|
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer.
|
Breast Cancer Res Treat
|
2002
|
2.71
|
|
6
|
Short telomere length and breast cancer risk: a study in sister sets.
|
Cancer Res
|
2007
|
2.70
|
|
7
|
Genomic DNA methylation among women in a multiethnic New York City birth cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
2.52
|
|
8
|
DNA methylation in white blood cells: association with risk factors in epidemiologic studies.
|
Epigenetics
|
2011
|
2.51
|
|
9
|
DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
|
J Natl Cancer Inst
|
2005
|
2.20
|
|
10
|
Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood.
|
Epigenetics
|
2011
|
2.12
|
|
11
|
Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use.
|
Am J Epidemiol
|
2005
|
2.03
|
|
12
|
Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
|
Clin Cancer Res
|
2007
|
2.02
|
|
13
|
Global methylation profiles in DNA from different blood cell types.
|
Epigenetics
|
2011
|
1.94
|
|
14
|
Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation.
|
Am J Gastroenterol
|
2002
|
1.81
|
|
15
|
Genome-wide DNA methylation profiles in hepatocellular carcinoma.
|
Hepatology
|
2012
|
1.81
|
|
16
|
Telomere length, oxidative damage, antioxidants and breast cancer risk.
|
Int J Cancer
|
2009
|
1.70
|
|
17
|
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry.
|
Cancer Res
|
2011
|
1.59
|
|
18
|
Choline metabolism and risk of breast cancer in a population-based study.
|
FASEB J
|
2008
|
1.51
|
|
19
|
Telomere length in hepatocellular carcinoma and paired adjacent non-tumor tissues by quantitative PCR.
|
Cancer Invest
|
2007
|
1.50
|
|
20
|
Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.50
|
|
21
|
Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.48
|
|
22
|
Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.
|
Anticancer Res
|
2010
|
1.46
|
|
23
|
Environmental tobacco smoke and breast cancer incidence.
|
Environ Res
|
2004
|
1.45
|
|
24
|
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
|
Hum Mutat
|
2002
|
1.44
|
|
25
|
Improving organochlorine biomarker models for cancer research.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.44
|
|
26
|
Association between plasma 25-hydroxyvitamin D and breast cancer risk.
|
Cancer Prev Res (Phila)
|
2009
|
1.44
|
|
27
|
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
|
Breast Cancer Res Treat
|
2008
|
1.40
|
|
28
|
Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
|
Epigenetics
|
2012
|
1.39
|
|
29
|
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer.
|
Prostate
|
2012
|
1.39
|
|
30
|
One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
|
Cancer Res
|
2005
|
1.38
|
|
31
|
Prenatal smoke exposure and genomic DNA methylation in a multiethnic birth cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.32
|
|
32
|
Physical activity and global genomic DNA methylation in a cancer-free population.
|
Epigenetics
|
2011
|
1.32
|
|
33
|
Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.28
|
|
34
|
Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
|
Carcinogenesis
|
2012
|
1.26
|
|
35
|
Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.
|
Cancer Lett
|
2005
|
1.23
|
|
36
|
Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.23
|
|
37
|
Multiple genetic variants in telomere pathway genes and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.23
|
|
38
|
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
|
Breast Cancer Res Treat
|
2011
|
1.22
|
|
39
|
Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.21
|
|
40
|
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis.
|
Arch Environ Health
|
2004
|
1.21
|
|
41
|
DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study.
|
FASEB J
|
2012
|
1.21
|
|
42
|
Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.21
|
|
43
|
Cooked meat and risk of breast cancer--lifetime versus recent dietary intake.
|
Epidemiology
|
2007
|
1.18
|
|
44
|
Dietary patterns are associated with levels of global genomic DNA methylation in a cancer-free population.
|
J Nutr
|
2011
|
1.17
|
|
45
|
Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.
|
Cancer Prev Res (Phila)
|
2010
|
1.17
|
|
46
|
Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.17
|
|
47
|
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
|
Breast Cancer Res Treat
|
2008
|
1.16
|
|
48
|
Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules.
|
Environ Health Perspect
|
2007
|
1.15
|
|
49
|
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
|
Mol Carcinog
|
2002
|
1.14
|
|
50
|
Exposures among pregnant women near the World Trade Center site on 11 September 2001.
|
Environ Health Perspect
|
2005
|
1.13
|
|
51
|
Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients.
|
Int J Cancer
|
2006
|
1.12
|
|
52
|
IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
|
Carcinogenesis
|
2005
|
1.11
|
|
53
|
Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
|
Epigenetics
|
2012
|
1.11
|
|
54
|
Active and passive cigarette smoke and breast cancer survival.
|
Ann Epidemiol
|
2007
|
1.11
|
|
55
|
Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.
|
Cancer Res
|
2004
|
1.10
|
|
56
|
Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.
|
Int J Cancer
|
2002
|
1.08
|
|
57
|
Susceptibility to arsenic-induced hyperkeratosis and oxidative stress genes myeloperoxidase and catalase.
|
Cancer Lett
|
2003
|
1.07
|
|
58
|
White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population.
|
Epigenetics
|
2012
|
1.07
|
|
59
|
Global DNA methylation levels in girls with and without a family history of breast cancer.
|
Epigenetics
|
2011
|
1.06
|
|
60
|
Polycyclic aromatic hydrocarbon-DNA adducts in human sperm as a marker of DNA damage and infertility.
|
Mutat Res
|
2003
|
1.06
|
|
61
|
Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study.
|
Carcinogenesis
|
2007
|
1.06
|
|
62
|
Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.05
|
|
63
|
A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users.
|
Am J Clin Nutr
|
2007
|
1.05
|
|
64
|
Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.
|
Carcinogenesis
|
2012
|
1.04
|
|
65
|
B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.04
|
|
66
|
ADH3 genotype, alcohol intake and breast cancer risk.
|
Carcinogenesis
|
2005
|
1.04
|
|
67
|
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
|
Cancer Epidemiol Biomarkers Prev
|
2014
|
1.03
|
|
68
|
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.
|
Free Radic Biol Med
|
2013
|
1.03
|
|
69
|
An improved liquid chromatography/tandem mass spectrometry method for the determination of 8-oxo-7,8-dihydro-2'-deoxyguanosine in DNA samples using immunoaffinity column purification.
|
Rapid Commun Mass Spectrom
|
2003
|
1.02
|
|
70
|
Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
|
Cancer Res
|
2009
|
1.02
|
|
71
|
Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma.
|
Epigenetics
|
2012
|
1.02
|
|
72
|
Adult global DNA methylation in relation to pre-natal nutrition.
|
Int J Epidemiol
|
2011
|
1.02
|
|
73
|
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
|
Breast Cancer Res
|
2006
|
1.01
|
|
74
|
Airborne particulate metals in the New York City subway: a pilot study to assess the potential for health impacts.
|
Environ Res
|
2010
|
1.01
|
|
75
|
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.
|
Cancer Prev Res (Phila)
|
2012
|
1.01
|
|
76
|
Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival.
|
Breast Cancer Res Treat
|
2009
|
1.01
|
|
77
|
Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells.
|
Cancer Res
|
2007
|
1.00
|
|
78
|
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke.
|
Carcinogenesis
|
2003
|
1.00
|
|
79
|
Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk.
|
Carcinogenesis
|
2007
|
0.99
|
|
80
|
High intakes of choline and betaine reduce breast cancer mortality in a population-based study.
|
FASEB J
|
2009
|
0.99
|
|
81
|
Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.
|
Carcinogenesis
|
2008
|
0.99
|
|
82
|
Oxidative and nitrosative stress markers in bus drivers.
|
Mutat Res
|
2007
|
0.98
|
|
83
|
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
|
Cancer Causes Control
|
2011
|
0.98
|
|
84
|
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
|
Int J Cancer
|
2003
|
0.98
|
|
85
|
Gene promoter methylation is associated with increased mortality among women with breast cancer.
|
Breast Cancer Res Treat
|
2009
|
0.97
|
|
86
|
Mutations in p53, p53 protein overexpression and breast cancer survival.
|
J Cell Mol Med
|
2008
|
0.96
|
|
87
|
PAH, genetic susceptibility and breast cancer risk: an update from the Long Island Breast Cancer Study Project.
|
Eur J Cancer
|
2008
|
0.96
|
|
88
|
Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females.
|
J Expo Anal Environ Epidemiol
|
2005
|
0.96
|
|
89
|
A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk.
|
Breast Cancer Res Treat
|
2004
|
0.96
|
|
90
|
Vehicular Traffic-Related Polycyclic Aromatic Hydrocarbon Exposure and Breast Cancer Incidence: The Long Island Breast Cancer Study Project (LIBCSP).
|
Environ Health Perspect
|
2015
|
0.96
|
|
91
|
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.96
|
|
92
|
Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.96
|
|
93
|
Validation and calibration of a model used to reconstruct historical exposure to polycyclic aromatic hydrocarbons for use in epidemiologic studies.
|
Environ Health Perspect
|
2006
|
0.95
|
|
94
|
Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells.
|
Carcinogenesis
|
2002
|
0.95
|
|
95
|
Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma.
|
Cancer Lett
|
2008
|
0.95
|
|
96
|
Plasma protein carbonyl levels and breast cancer risk.
|
J Cell Mol Med
|
2007
|
0.95
|
|
97
|
Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.
|
Breast Cancer Res Treat
|
2006
|
0.95
|
|
98
|
Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.
|
Biomarkers
|
2008
|
0.95
|
|
99
|
HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells.
|
Int J Cancer
|
2009
|
0.94
|
|
100
|
DNA repair gene XPD and susceptibility to arsenic-induced hyperkeratosis.
|
Toxicol Lett
|
2003
|
0.94
|
|
101
|
Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.
|
Antioxid Redox Signal
|
2013
|
0.94
|
|
102
|
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.
|
Amyotroph Lateral Scler Frontotemporal Degener
|
2014
|
0.94
|
|
103
|
Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.
|
PLoS One
|
2012
|
0.94
|
|
104
|
Genomic methylation changes over time in peripheral blood mononuclear cell DNA: differences by assay type and baseline values.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.93
|
|
105
|
Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
|
Carcinogenesis
|
2006
|
0.93
|
|
106
|
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
|
Breast Cancer Res Treat
|
2007
|
0.93
|
|
107
|
Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
|
Carcinogenesis
|
2008
|
0.93
|
|
108
|
Oxidative stress biomarkers in sporadic ALS.
|
Amyotroph Lateral Scler
|
2008
|
0.93
|
|
109
|
Biologic and epigenetic impact of commuting to work by car or using public transportation: a case-control study.
|
Prev Med
|
2012
|
0.93
|
|
110
|
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.
|
Cancer Lett
|
2008
|
0.93
|
|
111
|
Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
|
Breast Cancer Res
|
2004
|
0.90
|
|
112
|
Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.
|
Breast Cancer Res Treat
|
2012
|
0.90
|
|
113
|
XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study.
|
J Carcinog
|
2010
|
0.90
|
|
114
|
PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.
|
Environ Health Perspect
|
2008
|
0.90
|
|
115
|
Safety and efficacy of weekly oral oltipraz in chronic smokers.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.90
|
|
116
|
OGG1 polymorphisms and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.90
|
|
117
|
Early life socioeconomic factors and genomic DNA methylation in mid-life.
|
Epigenetics
|
2012
|
0.89
|
|
118
|
Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk.
|
Carcinogenesis
|
2006
|
0.89
|
|
119
|
Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
|
Environ Mol Mutagen
|
2002
|
0.89
|
|
120
|
Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.
|
J Nutr
|
2012
|
0.89
|
|
121
|
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas.
|
Cancer Causes Control
|
2007
|
0.89
|
|
122
|
Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.88
|
|
123
|
Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
|
Cancer Lett
|
2007
|
0.88
|
|
124
|
Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations.
|
Dig Dis Sci
|
2005
|
0.87
|
|
125
|
Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study.
|
Epigenetics
|
2007
|
0.87
|
|
126
|
Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
|
Mol Carcinog
|
2002
|
0.87
|
|
127
|
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
|
Carcinogenesis
|
2011
|
0.87
|
|
128
|
An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer.
|
Int J Cancer
|
2009
|
0.87
|
|
129
|
MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk.
|
Carcinogenesis
|
2005
|
0.87
|
|
130
|
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
|
Cancer Causes Control
|
2014
|
0.86
|
|
131
|
Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
|
Breast Cancer Res Treat
|
2006
|
0.86
|
|
132
|
Flow cytometric and immunoblot assays for cell surface ADP-ribosylation using a monoclonal antibody specific for ethenoadenosine.
|
Anal Biochem
|
2003
|
0.86
|
|
133
|
The definition of life: a survey of obstetricians and neonatologists in New York City hospitals regarding extremely premature births.
|
Matern Child Health J
|
2011
|
0.86
|
|
134
|
Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study.
|
Carcinogenesis
|
2008
|
0.86
|
|
135
|
Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.
|
Environ Res
|
2009
|
0.86
|
|
136
|
No effect of cigarette smoking dose on oxidized plasma proteins.
|
Environ Res
|
2007
|
0.86
|
|
137
|
Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
|
Breast Cancer Res Treat
|
2007
|
0.85
|
|
138
|
Expression of activated checkpoint kinase 2 and histone 2AX in exfoliative oral cells after exposure to ionizing radiation.
|
Radiat Res
|
2009
|
0.85
|
|
139
|
A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity.
|
Biomarkers
|
2003
|
0.85
|
|
140
|
Global DNA methylation in a population with aflatoxin B1 exposure.
|
Epigenetics
|
2013
|
0.85
|
|
141
|
DNA adducts in human placenta exposed to ambient environment and passive cigarette smoke during pregnancy.
|
Birth Defects Res A Clin Mol Teratol
|
2007
|
0.85
|
|
142
|
Organochlorine pesticide exposure in essential tremor: a case-control study using biological and occupational exposure assessments.
|
Neurotoxicology
|
2006
|
0.85
|
|
143
|
MnSOD Val-9Ala genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York.
|
Cancer Causes Control
|
2005
|
0.85
|
|
144
|
Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.85
|
|
145
|
Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups.
|
J Oncol
|
2009
|
0.85
|
|
146
|
The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study.
|
Epigenetics
|
2011
|
0.84
|
|
147
|
Indoor air pollution exposure from use of indoor stoves and fireplaces in association with breast cancer: a case-control study.
|
Environ Health
|
2014
|
0.84
|
|
148
|
Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry.
|
Breast Cancer Res Treat
|
2007
|
0.84
|
|
149
|
Gene-environment interactions between DNA repair polymorphisms and exposure to the carcinogen vinyl chloride.
|
Biomarkers
|
2009
|
0.84
|
|
150
|
Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.
|
Carcinogenesis
|
2008
|
0.83
|
|
151
|
The role of XRCC1 polymorphisms in base excision repair of etheno-DNA adducts in French vinyl chloride workers.
|
Int J Occup Med Environ Health
|
2006
|
0.83
|
|
152
|
Role and limitations of epidemiology in establishing a causal association.
|
Semin Cancer Biol
|
2004
|
0.83
|
|
153
|
No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.83
|
|
154
|
Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial.
|
Urology
|
2008
|
0.83
|
|
155
|
DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer.
|
DNA Cell Biol
|
2011
|
0.82
|
|
156
|
Application of an immunoperoxidase staining method for detection of 7,8-dihydro-8-oxodeoxyguanosine as a biomarker of chemical-induced oxidative stress in marine organisms.
|
Aquat Toxicol
|
2004
|
0.82
|
|
157
|
Oxidative damage to DNA: an immunohistochemical approach for detection of 7,8-dihydro-8-oxodeoxyguanosine in marine organisms.
|
Mar Environ Res
|
2004
|
0.82
|
|
158
|
Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.
|
World J Hepatol
|
2012
|
0.81
|
|
159
|
Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study.
|
Carcinogenesis
|
2007
|
0.81
|
|
160
|
Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer.
|
Int J Cancer
|
2004
|
0.81
|
|
161
|
Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk.
|
Int J Cancer
|
2013
|
0.81
|
|
162
|
Genetic variation in telomere maintenance genes, telomere length and breast cancer risk.
|
PLoS One
|
2012
|
0.81
|
|
163
|
Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.
|
Eur J Cancer
|
2007
|
0.81
|
|
164
|
GSTM1 [corrected] deletion modifies the levels of polycyclic aromatic hydrocarbon-DNA adducts in human sperm.
|
Mutat Res
|
2005
|
0.80
|
|
165
|
DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR).
|
Cancer Causes Control
|
2013
|
0.80
|
|
166
|
Effect of selenium and vitamin e supplementation on plasma protein carbonyl levels in patients with arsenic-related skin lesions.
|
Nutr Cancer
|
2008
|
0.80
|
|
167
|
Lack of associations among cancer and albumin adducts, ras p21 oncoprotein levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a nested case-control study of lung cancer within the physicians' health study.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.80
|
|
168
|
Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk.
|
Cancer Causes Control
|
2012
|
0.80
|
|
169
|
Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population.
|
Cancer Sci
|
2007
|
0.80
|
|
170
|
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner.
|
Mol Cancer Ther
|
2003
|
0.80
|
|
171
|
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.
|
Breast Cancer Res
|
2011
|
0.79
|
|
172
|
Immunofluorescent detection of 8-oxo-dG and PAH bulky adducts in fish liver and mussel digestive gland.
|
Aquat Toxicol
|
2005
|
0.78
|
|
173
|
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.
|
Cancer Prev Res (Phila)
|
2010
|
0.78
|
|
174
|
Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.
|
Cancer Causes Control
|
2013
|
0.77
|
|
175
|
Polycyclic aromatic hydrocarbon-DNA adducts among rickshaw drivers in Dhaka City, Bangladesh.
|
Int Arch Occup Environ Health
|
2003
|
0.77
|
|
176
|
Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.
|
Cancer Res
|
2008
|
0.77
|
|
177
|
Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.
|
Hepat Res Treat
|
2011
|
0.77
|
|
178
|
Correlations in global DNA methylation measures in peripheral blood mononuclear cells and granulocytes.
|
Epigenetics
|
2014
|
0.77
|
|
179
|
Topical Application of Green Tea Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) for Prevention of Recurrent Oral Neoplastic Lesions.
|
J Orofac Sci
|
2012
|
0.76
|
|
180
|
Effect of the XRCC1 codon 399 polymorphism on the repair of vinyl chloride metabolite-induced DNA damage.
|
J Carcinog
|
2009
|
0.76
|
|
181
|
IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.
|
Breast Cancer Res Treat
|
2006
|
0.76
|
|
182
|
8-oxo-dG elevated in children during leukemia treatment.
|
Integr Cancer Ther
|
2004
|
0.75
|
|
183
|
Subgroup report: head and neck cancer.
|
IARC Sci Publ
|
2004
|
0.75
|
|
184
|
In situ quantification of aberrant p53 in colorectal neoplasia.
|
Biomarkers
|
2003
|
0.75
|